Methods
US11053245B2 · kind B2 · utility
28Cited by
73References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2013 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | Sep 22, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals for the treatment of agitation, aggressive behaviors, posttraumatic stress disorder or impulse control disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.